Actylis, a global leader in specialty ingredients for life sciences, has announced its acquisition of Pharm-Rx, a prominent distributor of specialty ingredients for the vitamin, mineral, supplement (VMS), and pharmaceutical industries.
For over 30 years, Pharm-Rx has built a reputation for sourcing difficult-to-find specialty ingredients and offering value-added services to the VMS and pharmaceutical markets. The acquisition will expand Actylis’ nutraceutical capabilities and broaden its portfolio of solutions for clients in the growing nutrition and over-the-counter (OTC) pharmaceutical markets.
This acquisition is a significant milestone for Actylis as it continues to strengthen its presence in the life sciences industry. The integration of Pharm-Rx's expertise and client-centric approach aligns perfectly with Actylis' commitment to delivering innovative solutions and exceptional value to customers worldwide.
"Pharm-Rx brings a wealth of experience and a customer-first approach that complements our business. We look forward to working together to drive growth and unlock new opportunities for our customers," said Scott Thomson, CEO of Actylis.
Pharm-Rx will continue to operate under its current brand, and its leadership team will remain intact to ensure continuity and smooth integration.
For more information, visit www.actylis.com
